BSE/TSE risks associated with active pharmaceutical ingredients and starting materials: the situation in Europe and the global implications for healthcare manufacturers

PDA J Pharm Sci Technol. 2001 Sep-Oct;55(5):295-328.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Industry*
  • Equipment and Supplies
  • Europe
  • Health Care Sector*
  • Humans
  • Occupational Exposure / prevention & control*
  • Prion Diseases / epidemiology
  • Prion Diseases / transmission*